Study on Rare Metabolic Disorder (Primary Hyperoxaluria Type 1) among Children: Perspectives to Genotyping and Outcome

Authors

  • Mohamed S. Al Riyami Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, P.O.Box 1331, 111 Muscat, Oman.
  • Badria Al Ghaithi Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, P.O.Box 1331, 111 Muscat, Oman.
  • Nadia Al Hashmi Metabolic and Genetic UNIT, Department of Child Health, Royal Hospital, P.O.Box 1331, 111 Muscat, Oman.
  • Naifain Al Kalbani Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, P.O.Box 1331, 111 Muscat, Oman.

DOI:

https://doi.org/10.9734/bpi/cdhr/v9/8613D

Keywords:

Metabolic disorders, Primary hyperoxaluria, AGXT gene, genetic mutations

Abstract

Background: Primary hyperoxaluria belongs to a group of rare metabolic disorders with autosomal recessive inheritance. It results from genetic mutations of the AGXT gene, which is more common due to higher consanguinity rates in the developing countries. Clinical features at presentation are heterogeneous even in children from the same family; this study was conducted to determine the clinical characteristics, type of AGXT mutation, and outcome in children diagnosed with PH1 at a tertiary referral center in Oman.

Method: Retrospective review of children diagnosed with PH1 at a tertiary hospital in Oman from 2000 to 2013.

Results: Total of 18 children were identified. Females composed 61% of the children with median presentation age of 7 months. Severe renal failure was initial presentation in 39% and 22% presented with nephrocalcinosis and/or renal calculi. Family screening diagnosed 39% of patients. Fifty percent of the children underwent hemodialysis. 28% of children underwent organ transplantation. The most common mutation found in Omani children was c.33-34insC mutation in the AGXT gene.

Conclusion: Due to consanguinity, PH1 is a common cause of ESRD in Omani children. Genetic testing is recommended to help in family counseling and helps in decreasing the incidence and disease burden; it also could be utilized for premarital screening. This report is the first from Oman and the gulf region; it highlights the huge disease burden of an autosomal recessive mutation and importance of family screening and genetic counseling.

Published

2021-06-30

How to Cite

Mohamed S. Al Riyami, Badria Al Ghaithi, Nadia Al Hashmi, & Naifain Al Kalbani. (2021). Study on Rare Metabolic Disorder (Primary Hyperoxaluria Type 1) among Children: Perspectives to Genotyping and Outcome. Challenges in Disease and Health Research Vol. 9, 5–13. https://doi.org/10.9734/bpi/cdhr/v9/8613D